本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

BioNTech SE

110.02
-1.0200-0.92%
盘后110.00-0.0200-0.02%19:39 EDT
成交量:61.66万
成交额:6,781.16万
市值:264.05亿
市盈率:-31.91
高:111.78
开:111.78
低:109.48
收:111.04
数据加载中...
2024/09/16

关联方拟减持公告

Form 144 | BioNTech SE 10%股东 ATHOS KG 拟减持50万股,总价约6170万美元
2024/09/16

关联方拟减持公告

Form 144 | BioNTech SE 股东 ATHOS KG 拟减持90000股,总价约1134万美元
2024/09/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/20

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/21

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2024/02/15

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/07

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/03/27

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/02/22

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/13

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/02/13

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/10/26

[修订]年度报告

20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]